News

Experimental weight-loss drug retatrutide shows substantial knee-pain relief in osteoarthritis trial

An experimental weight-loss drug called retatrutide reduced knee pain and body weight in people with knee osteoarthritis. At the highest dose, participants lost about 25% of their body weight, while roughly two-thirds experienced at least a 50% reduction in knee pain.

The results indicate that treating obesity may also ease a major symptom of osteoarthritis. However, researchers still do not know whether retatrutide can prevent the knee joint from deteriorating further, so its long-term structural benefits remain uncertain.

Sources